Saturday, June 28

07.00

Breakfast

08.00

CLINICAL ASPECTS AND ISSUES OF EOSINOPHIL FUNCTION IN DISEASE I: PATHOPHYSIOLOGIC ACTIVITIES IN THE AIRWAYS IN ASTHMA
Session Chairs – Bill Busse and Per Venge

08.00-08.20

Douglas Robinson (Imperial College, National Heart & Lung Inst., London, UK)
"The effect of anti-IL-5 treatment on airway and bone marrow eosinophils and precursors in human asthma: a reprise for eosinophils?"

08.20-08.40

David Broide (University of California – San Diego, La Jolla, CA, USA)
"The role of the eosinophil in airway remodeling"

08.40-09.00

A. Barry Kay (Imperial College, National Heart & Lung Institute, London, UK)
“Evidence for a role for eosinophils in airways remodeling – lessons from trials of anti-IL-5”

09.00-09.20 

Francesca Levi-Shaffer (Hebrew University, Jerusalem, Israel)
"Eosinophils and the allergic microenvironment"

09.20-09.40

Andrew Wardlaw (Glenfield Hospital, Leicester, UK)
“Sputum eosinophils in asthma diagnosis and treatment”

09.40

Refreshments and Open Poster Viewing

10.20-12.20

Oral Communications of Submitted Abstracts
(10 x 12 minute talks)
Chairs: Nives Zimmermann and Rafeul Alam

12.30-14.30

Unscheduled Time for the 3Rs – Rest, Relaxation, Recreation

12.30-14.30

Executive Board Committee Meeting - the International Eosinophil Society

14.30

CLINICAL ASPECTS AND ISSUES OF EOSINOPHIL FUNCTION IN DISEASE II: PATHOPHYSIOLOGIC ACTIVITIES IN ALLERGIC RESPONSES AND GASTRO-INTESTINAL, DERMATOLOGIC AND PARASITIC DISEASES
Session Chairs – Gerald Gleich and Kristin Leiferman

14.30-14.50

Per Venge (University Hospital, Uppsala, Sweden)
“ECP polymorphisms in relation to disease”

14.50-15.10 

Paul O’Byrne (McMaster University, Hamilton, Ontario, Canada)
“Eosinophils, eicosanoids and allergen responses – therapeutic implications”

15.10-15.30

Glenn Furuta (Children’s Hospital, Harvard Medical School, Boston, MA, USA)
“Impact of eosinophils in esophageal inflammation: The emerging entity of eosinophilic esophagitis”

15.30-15.50

Kristin Leiferman (University of Utah, Salt Lake City, UT, USA)
“Roles of eosinophils in dermatologic diseases”

15.50-16.10

Hirohito Kita (Mayo Clinic, Rochester, MN, USA)
“Mechanisms of eosinophil activation and degranulation in innate immunity”

16.10-16.30

Thomas Nutman (Laboratory of Parasitic Diseases, NIH, Bethesda, MD, USA)
“Tropical pulmonary eosinophilia as the prototype for helminth-induced eosinophil-mediated pathology”

16.30-17.30

Poster Viewing of Submitted Abstracts - Session II
(presenting authors of ODD numbered posters available for discussion)

17.15-17:45

Transport to the Barbecue Dinner and Rodeo Entertainment

17.45

Barbeque Dinner and the Rodeo

Next Page